KRAS is widely known as the critical driver that enables unlimited proliferation, apoptosis resistance, and metastasis in pancreatic cancer cells and promotes metabolic alterations for the sustenance of biosynthetic pathways. This evidence concerns the gene KRAS and familial pancreatic carcinoma.